Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia

BACKGROUND: The present study investigated factors associated with therapeutic benefits after autologous bone marrow cell (BMC) therapy in patients with “no-option” critical limb ischemia (CLI). METHODS AND RESULTS: Sixty-two patients with advanced CLI (Rutherford category 5 or 6) not eligible for r...

Descripción completa

Detalles Bibliográficos
Autores principales: Madaric, Juraj, Klepanec, Andrej, Valachovicova, Martina, Mistrik, Martin, Bucova, Maria, Olejarova, Ingrid, Necpal, Roman, Madaricova, Terezia, Paulis, Ludovit, Vulev, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987968/
https://www.ncbi.nlm.nih.gov/pubmed/27530339
http://dx.doi.org/10.1186/s13287-016-0379-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987968/
https://www.ncbi.nlm.nih.gov/pubmed/27530339
http://dx.doi.org/10.1186/s13287-016-0379-z

Ejemplares similares